Medical Devices Industry Reports Foam Dressing Market | Page 3

Foam Dressing Market Growth, Future Prospects and Competitive Analysis and Forecast
Foam Dressing plays an important role in the healing process in near future
Request a sample copy of Foam Dressing Market Report: http://bit.ly/2BLMMmw
Foam dressing is effective for managing exuding wounds by providing a moist environment
conducive to the wound healing and reducing dressing pain and discomfort. Increasing surgical
cosmetic procedures around the globe is expected to propel growth of the foam dressing market. For
instance, according to The International Society of Aesthetic Plastic Surgery 2016 survey report, an
overall increase of 9% was observed in surgical and non-surgical cosmetic procedures from 2015 to
2016.
Introduction of new products by key players is expected to propel growth of the foam dressing
market. For instance, in 2016, ConvaTec, a leading medical technology company, launched Foam
Lite, a light, flexible foam dressing developed for low to non-exuding chronic and acute wounds
such as skin tears, partial thickness burns, and skin abrasions which do not require the absorbency
of regular foam dressings.
For instance, in 2015, Devon Medical Products Inc. received a Food and Drug Administration
(FDA) 510(k) clearance for its extriCARE 2400 negative pressure wound therapy (NPWT) pump to
operate with its foam dressing kit.
Immunofluorescence Analyzer Market | Competitive Analysis, Industry Dynamics, Growth Factors
& Opportunities
Immunofluorescence Analyzer Market Positive Growth by Revenue and Key Players Forecast by
2026
Request a sample copy of Immunofluorescence Analyzer Market Report: http://bit.ly/2oachVc
Immunofluorescence assays are different type of immunoassays. The advantages of a fluorescent
detection system include higher sensitivity recognition of an analyte, simpler assay designs, and
simplified reagents. Over the past few decades various advancements such as portability,
compactness and real time monitoring of analyzer have supported the application of fluorescent-
based immunoassay system in point-of-care.
For instance, in 2017, Siemens Healthineers launched the Atellica Solution, an immunoassay and
clinical chemistry solution that is highly flexible, which included patented magnetic bi-directional
sample transport technology that is 10 times quicker than conventional system. The solution can be
used as scalable stand-alone system that offers 300 customizable configurations including U-shaped
and L-shaped, and is scalable up to 10 components.
Abbott received FDA approval for its Alinity ci-series instruments. The portfolio includes
immunoassay diagnostics, clinical chemistry, blood and plasma screening, point-of-care,
hematology, and AlinIQ holistic suite, which provides professional services with informatics and
process analysis.